Zymeworks (ZYME) Cash from Operations (2021 - 2026)
Zymeworks recorded quarterly Cash from Operations of 45718000.0 in Q1 2026, down 345.64% quarter-over-quarter from 10259000.0 in Q4 2025, and down 1241.88% year-over-year from 4003732.93 in Q1 2025.
Zymeworks' Cash from Operations history runs 6 years deep, the most recent figure standing at 45718000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 1241.88% year-over-year to 45718000.0; the TTM figure through Mar 2026 stood at 75316000.0 (up 0.63% YoY), while the FY2025 annual figure was 33005000.0, up 70.01% from the prior year.
- Cash from Operations came in at 45718000.0 for Q1 2026 at Zymeworks, down from 10259000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 327360000.0 in Q4 2022 to a low of 83191000.0 in Q1 2023.
- A 5-year average of 9588000.0 and a median of 31412000.0 in 2025 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations surged 748.12% in 2022 and tumbled 1241.88% in 2026, its largest moves.
- Zymeworks' Cash from Operations stood at 327360000.0 in 2022, then sank by 95.74% to 13933000.0 in 2023, then plunged by 397.93% to 41510000.0 in 2024, then surged by 75.29% to 10259000.0 in 2025, then plunged by 345.64% to 45718000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 45718000.0, 10259000.0, and 31412000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - | -45.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.72 Mn |
| Mar 31, 2026 | -45.72 Mn |
| Dec 31, 2025 | -10.26 Mn |
| Dec 31, 2025 | -10.26 Mn |
| Sep 30, 2025 | -31.41 Mn |
| Sep 30, 2025 | -31.41 Mn |
| Jun 30, 2025 | 12.07 Mn |
| Jun 30, 2025 | 12.07 Mn |
| Mar 31, 2025 | -3.41 Mn |
| Mar 31, 2025 | -3.41 Mn |
| Dec 31, 2024 | -41.51 Mn |
| Dec 31, 2024 | -41.51 Mn |
| Sep 30, 2024 | -5.88 Mn |
| Sep 30, 2024 | -5.88 Mn |
| Jun 30, 2024 | -24.99 Mn |
| Jun 30, 2024 | -24.99 Mn |
| Mar 31, 2024 | -37.68 Mn |
| Mar 31, 2024 | -37.68 Mn |
| Dec 31, 2023 | 13.93 Mn |
| Dec 31, 2023 | 13.93 Mn |
| Sep 30, 2023 | -42.67 Mn |
| Sep 30, 2023 | -42.67 Mn |
| Jun 30, 2023 | -6.40 Mn |
| Jun 30, 2023 | -6.40 Mn |
| Mar 31, 2023 | -83.19 Mn |
| Mar 31, 2023 | -83.19 Mn |
| Dec 31, 2022 | 327.36 Mn |
| Dec 31, 2022 | 327.36 Mn |
| Sep 30, 2022 | -73.02 Mn |
| Sep 30, 2022 | -73.02 Mn |
| Jun 30, 2022 | -54.82 Mn |
| Jun 30, 2022 | -54.82 Mn |
| Mar 31, 2022 | -55.41 Mn |
| Mar 31, 2022 | -55.41 Mn |
| Dec 31, 2021 | -50.51 Mn |
| Dec 31, 2021 | -50.51 Mn |